ArticleNeuro-oncology2020

Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma.

Wen-Bin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.